You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil

Not yet recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Lenacapavir Injection
  • +2 more
  • (no location specified)
Oct 20, 2023

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

HIV/AIDS, Adherence, Medication, Drug Use Trial in Norfolk (Tenofovir Disoproxil Fumarate)

Completed
  • HIV/AIDS
  • +2 more
  • Tenofovir Disoproxil Fumarate
  • Norfolk, Virginia
    Clinical Research Center, Eastern Virginia Medical School
Apr 12, 2022

Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200

Recruiting
  • Drug Interaction
  • Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
  • Bangkok, Pathumwan, Thailand
    Institute of HIV Research and Innovation (IHRI)
Apr 21, 2022

HIV Infection Trial in Puerto Rico, United States (Maraviroc, Emtricitabine, Tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV Infection
  • Los Angeles, California
  • +12 more
Nov 3, 2021

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

Active, not recruiting
  • HIV-1/HBV Co-Infection
  • Fort Pierce, Florida
  • +66 more
Sep 19, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR)-004, Truvada Tablet)

Completed
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)-004
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Nov 17, 2022

HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)

Recruiting
  • HIV/AIDS
  • Tuberculosis, Pulmonary
  • Biktarvy®
  • TLD- fixed-drug combination single tablet
  • Durban, KwaZulu-Natal, South Africa
    CAPRISA Springfield Clinical Research Site
Mar 14, 2022

HIV-1 Infection Trial in Worldwide (B/F/TAF)

Completed
Has Results
  • HIV-1 Infection
  • Brussels, Belgium
  • +24 more
Nov 6, 2020

HIV Trial in Nijmegen (Stribild, Stribild, crushed)

Completed
  • HIV
  • Nijmegen, Netherlands
    CRCN, Radboud University Medical Center
Mar 11, 2021

"Observational Study on Tolerability and Observance of

Not yet recruiting
  • HIV Infections
  • (no location specified)
Feb 27, 2023

Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

Completed
  • Medication Adherence
  • HIV
  • dolutegravir oral tablet 50mg
  • +3 more
  • Pittsburgh, Pennsylvania
    HIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022

HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Recruiting
  • HIV Infections
  • Renal Transplant Rejection
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

HIV Trial in San Diego (Stribild, Genvoya)

Completed
Has Results
  • HIV
  • San Diego, California
    UC San Diego AntiViral Research Center
Oct 8, 2019

HIV/AIDS Trial (Elvitegravir, Cobicistat, TAF, FTC, Efavirenz, TDF, and 3TC)

Withdrawn
  • HIV/AIDS
  • Elvitegravir, Cobicistat, TAF, FTC
  • Efavirenz, TDF, and 3TC
  • (no location specified)
Mar 16, 2020

Healthy Volunteers Trial in Baltimore (Genvoya Oral dose, Genvoya Crushed Dose)

Completed
  • Healthy Volunteers
  • Genvoya Oral dose
  • Genvoya Crushed Dose
  • Baltimore, Maryland
    Johns Hopkins University
Nov 9, 2021

HIV-1 Infection Trial in Worldwide (E/C/F/TAF, E/C/F/TDF, ATV)

Completed
Has Results
  • HIV-1 Infection
  • Stamford, Connecticut
  • +55 more
Feb 18, 2020

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

HIV-1 Infection Trial in Worldwide (E/C/F/TAF)

Completed
Has Results
  • HIV-1 Infection
  • Fort Pierce, Florida
  • +20 more
Jul 9, 2020

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

Hiv, Prophylaxis, Transgender Trial in Baltimore (Truvada alone, Truvada plus Leuprolide, Truvada plus Estradiol 1 mg)

Recruiting
  • Hiv
  • +2 more
  • Truvada alone
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine Drug Development Unit
Mar 8, 2022

HIV, Adolescent Behavior, Gender Trial in New York, Kisumu, Nairobi (other, drug, behavioral)

Completed
  • HIV
  • +2 more
  • Male-Specific Intervention Package
  • +3 more
  • New York, New York
  • +2 more
Feb 2, 2022